Georgios Deftereos, MD

Associate Professor (Clinical), University of Utah School of Medicine

Specialities

• Cytopathology
• Molecular oncologic pathology

Education

• Medical Degree—University of Bari Aldo Moro
• Residency—Anatomic and Clinical Pathology, Allegheny Health Network
• Fellowship—Cytopathology, University of Washington
• Fellowship—Molecular Genetic Pathology, University of Washington

Certification/Affiliations

• American Board of Pathology (Anatomic and Clinical Pathology, Cytopathology, Molecular Genetic Pathology)

Research Interests

• Epigenetics of solid tumors
• Minimally invasive precision diagnostics
• Molecular testing in cytopathology of solid tumors

Awards

• 40 Under Forty Award, American Society for Clinical Pathology, 2016
• First Resident Research Award, Papanicolaou Society of Cytopathology, United States and Canada Academy of Pathology, 2015
• Poster of Distinction Award, Digestive Disease Week, 2013
• First Place, Resident Research Award, Papanicolaou Society of Cytopathology, United States and Canada Academy of Pathology, 2012

Recent Publications

• Deftereos G, et al. Differential outcomes of patients with thyroid FNA diagnoses of AUS versus FLUS: the potential need for separation in the Bethesda System. Diagn Cytopathol. 2020;48(7):610–17.
• Deftereos G, et al. Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue. Hum Pathol. 2020;97:52–9.
• Sirohi D, et al. Multi-institutional evaluation of the 2017 AMP, ASCO, and CAP standards and guidelines for the interpretation and reporting of sequence variants in cancer. J Mol Diagn. 2020;22(2):284–93.